...
首页> 外文期刊>RSC Advances >Selective recognition of c-myc promoter G-quadruplex and down-regulation of oncogene c-myc transcription in human cancer cells by 3,8a-disubstituted indolizinone
【24h】

Selective recognition of c-myc promoter G-quadruplex and down-regulation of oncogene c-myc transcription in human cancer cells by 3,8a-disubstituted indolizinone

机译:3,8 -双取代的吲哚嗪酮对人癌细胞中c-myc启动子G-四链体的选择性识别和癌基因c-myc转录下调

获取原文

摘要

C-myc promoter G-quadruplex is a very important target for developing anti-cancer drugs. However, highly selective recognition of DNA c-myc G-quadruplex with parallel configuration is also a very challenging problem. Here, we showed a new type of N-containing alkaloid, 3,8a-disubstituted indolizinone, which adopted a distorted configuration. 6-Methyl-3-(naphthalen-2-yl)-8a-(4-methylpyridin-2-yl)-indolizinone could selectively recognize DNA c-myc G-quadruplex leading to an obvious fluorescence enhancement by 11-fold, and meanwhile the G-quadruplex can be stabilized up to 90 °C. Further, it could down-regulate the transcription of oncogene c-myc in both human non-small cell line (A549) and human laryngeal epithelial cell line (Hep-2).
机译:C-myc启动子G-四链体是开发抗癌药物的重要目标。然而,具有平行构型的DNA c-myc G-四链体的高度选择性识别也是一个非常具有挑战性的问题。在这里,我们展示了一种新型的含氮生物碱3,8 a -二取代的吲哚嗪酮,其结构呈扭曲形。 6-甲基-3-(萘-2-基)-8 a -(4-甲基吡啶-2-基)-吲哚嗪酮可选择性识别DNA c-myc G-四链体,从而产生明显的荧光增强了11倍,同时G-四链体可以稳定到90°C。此外,它可以下调人非小细胞系(A549)和人喉上皮细胞系(Hep-2)中癌基因c-myc的转录。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号